| Literature DB >> 29907436 |
Todd S Horowitz1, Jerry Suls2, Melissa Treviño2.
Abstract
Cancer-related cognitive impairment (CRCI) is a widespread problem for the increasing population of cancer survivors. Our understanding of the nature, causes, and prevalence of CRCI is hampered by a reliance on clinical neuropsychological methods originally designed to detect focal lesions. Future progress will require collaboration between neuroscience and clinical neuropsychology. Published by Elsevier Ltd.Entities:
Keywords: cancer; chemobrain; chemotherapy; cognitive impairment; neuroimaging; neuropsychological tests; survivorship
Mesh:
Year: 2018 PMID: 29907436 DOI: 10.1016/j.tins.2018.05.001
Source DB: PubMed Journal: Trends Neurosci ISSN: 0166-2236 Impact factor: 13.837